Literature DB >> 1936599

Structural and functional considerations of GABA in islets of Langerhans. Beta-cells and nerves.

R L Sorenson1, D G Garry, T C Brelje.   

Abstract

gamma-Aminobutyric acid (GABA), a prominent inhibitory neurotransmitter, is present in high concentrations in beta-cells of islets of Langerhans. The GABA shunt enzymes, glutamate decarboxylase (GAD) and GABA transaminase (GABA-T), have also been localized in islet beta-cells. With the recent demonstration that the 64,000-M, antigen associated with insulin-dependent diabetes mellitus is GAD, there is increased interest in understanding the role of GABA in islet function. Only a small component of beta-cell GABA is contained in insulin secretory granules, making it unlikely that GABA, coreleased with insulin, is physiologically significant. Our immunohistochemical study of GABA in beta-cells of intact islets indicates that GABA is associated with a vesicular compartment distinctly different from insulin secretory granules. Whether this compartment represents a releasable pool of GABA has yet to be determined. GAD in beta-cells is associated with a vesicular compartment, similar to the GABA vesicles. In addition, GAD is found in a unique extensive tubular cisternal complex (GAD complex). It is likely that the GABA-GAD vesicles are derived from this GAD-containing complex. Physiological studies on the effect of extracellular GABA on islet hormonal secretion have had variable results. Effects of GABA on insulin, glucagon, and somatostatin secretion have been proposed. The most compelling evidence for GABA regulation of islet hormone secretion comes from studies on somatostatin secretion, where it has an inhibitory effect. We present new evidence demonstrating the presence of GABAergic nerve cell bodies at the periphery of islets with numerous GABA-containing processes extending into the islet mantle. This close association between GABAergic neurons and islet alpha- and delta-cells strongly suggests that GABA inhibition of somatostatin and glucagon secretion is mediated by these neurons. Intracellular beta-cell GABAA and its metabolism may have a role in beta-cell function. New evidence indicates that GABA shunt activity is involved in regulation of insulin secretion. In addition, GABA or its metabolites may regulate proinsulin synthesis. These new observations provide insight into the complex nature of GABAergic neurons and beta-cell GABA in regulation of islet function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936599     DOI: 10.2337/diab.40.11.1365

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

Review 1.  Colocalization of amino acid signal molecules in neurons and endocrine cells.

Authors:  S Davanger
Journal:  Anat Embryol (Berl)       Date:  1996-07

2.  Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.

Authors:  Liron Abuhatzira; Huanyu Xu; Georges Tahhan; Afroditi Boulougoura; Alejandro A Schäffer; Abner L Notkins
Journal:  FASEB J       Date:  2015-07-06       Impact factor: 5.191

3.  Multiple exocytotic pathways in pancreatic beta cells.

Authors:  N Takahashi; T Kadowaki; Y Yazaki; Y Miyashita; H Kasai
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

4.  Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region.

Authors:  M Solimena; D Aggujaro; C Muntzel; R Dirkx; M Butler; P De Camilli; A Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.

Authors:  G Sundkvist; L A Velloso; O Kämpe; S L Rabinowe; S A Ivarsson; B Lilja; F A Karlsson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 6.  GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.

Authors:  M Solimena; M H Butler; P De Camilli
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

7.  Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.

Authors:  L A Velloso; O Kämpe; A Hallberg; L Christmanson; C Betsholtz; F A Karlsson
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 8.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Deficient activity of FAD-linked glycerophosphate dehydrogenase in islets of GK rats.

Authors:  C G Ostenson; S M Abdel-Halim; J Rasschaert; F Malaisse-Lagae; S Meuris; A Sener; S Efendic; W J Malaisse
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

10.  Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.

Authors:  W Richter; T H Eiermann; J Endl; J Seissler; S Wolfahrt; M Brandt; H Jungfer; W A Scherbaum
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.